Advertisement Haselmeier - Pharmaceutical Business review - Self-Injection Devices
Pharmaceutical Business review is using cookies

ContinueLearn More


Self-Injection Devices Developer and Manufacturer



Haselmeier is a leading developer and manufacturer of innovative self-injection devices featuring proprietary designs, technology and intellectual property (IP).

With more than four decades of medical device experience, Haselmeier has built up a world-class design and development team that works in compliance with regulatory requirements for the creation, design and industrialisation of our innovative self-injection systems used by pharmaceutical and biotechnology companies worldwide.

Headquartered in Switzerland, the Haselmeier Group employs approximately 200 team members worldwide and has a presence in Europe, the US, India and China.

Products are manufactured at state-of-the-art manufacturing sites located in Buchen im Odenwald (Germany), Dnesice (Czech Republic) and Bangalore (India).

Working together to inspire your patients

User Focus

Haselmeier’s mission is to create products enabling a convenient and comfortable experience. This is why patient feedback is integrated early in our device designs.

Early concepts are prototyped for testing and Human Factors studies to capture the handling needs and skills of potential users. This knowledge is integrated into the device design to provide successful administration of the drug product and a positive user experience.

Haselmeier offers a range of early-stage activities:

•   Think-tank discussions and paper concepts
•   Detailed product concepts and industrial designs
•   Detailed user handling review and risk-analysis
•   Prototyping of initial concepts up to functional devices
•   User focus groups and human factors studies for concept and prototype evaluations
•   Detailed user requirements and product design specifications based on selected concept

Bridge to market

Successful development and industrialization of drug delivery devices is dependent upon the understanding and execution of today’s technical, regulatory and operational requirements.

At Haselmeier we provide integrated design, development and industrialization services to help you bridge your serial product into the market. Our qualified design control process, certified quality system, regulatory expertise, solid network of partners and strong manufacturing operations are all designed to achieve your expectations. Together we enable a smooth market introduction for your commercial drug delivery device.

Haselmeier’s commercial development and industrialization services include:

•  Concept transfer into detailed user requirements and product design specifications
•  A certified design control process and quality system
•  Design verification, product and process validation processes
•  Regulatory expertise to support your approval strategy
•  Controlled design-to-manufacturing transfer, verification and validation

Manufacturing & lifecycle partner

We understand that each customer has individual and specific requirements for their product. Regardless of your requirements, Haselmeier applies the highest standard for manufacturing your drug delivery device to ensure a reliable and reproducible manufacturing and quality process. We work continuously with our customers to identify product improvements at all stages of the product’s lifecycle to provide a safe and state-of-the-art drug delivery device.

Haselmeier provides flexible, reliable, manufacturing and lifecycle management:

•   Certified and modern production facilities and manufacturing processes
•  Qualified and well-trained personnel
•  A strong network of sub-suppliers and manufacturing partners
•  Continuous engineering and product improvement program
•  Innovation meetings to identify next product generation


Nadia Di Secli
Haselmeier AG
Dufourstrasse 32
8008 Zürich

Phone: +(41) 44 250 58 50

Quick Contact Haselmeier


The Haselmeier Axis-D pen system is a disposable, variable dose injection device designed for the use with a 3ml cartridge. The elegant and compact Axis-D pen system is available as a high-quality plastic version. Key features include: Available as disposable Variable dosage with a dose adjustment ranging from 0.01ml to 0.6ml, customisable to alternative dose…


The D-Flex is a disposable injection pen that uses 3ml cartridges. It is available in two versions that are designed to cover a freely selectable, regular or irregular dose regimen. The platform can be set to deliver a single dose or a number of fixed doses. Its proprietary mechanism prevents unintended dose selection, improving safety,…


The Haselmeier i-pen² is a reusable, variable dose injection device designed for use with a standard 3ml cartridge. The i-pen² features an attractive design and high variability for customisation and choice of colour. The i-pen² has been created through extensive research and patient testing. It is designed to meet the needs of self-injecting patients. The…


The Haselmeier i-pen is a reusable, variable dose injection device designed for use with a standard 3ml cartridge. The i-pen is designed attractively and can be customised too. Designed through ample research and patient testing, the i-pen is designed to meet the needs of self-injection patients. The i-pen is available as a standard Haselmeier design…


The Penlet is the only disposable multi-injection autoinjector for 3ml cartridges. The Haselmeier disposable Penlet is a fully-automated, multi-dose, fixed dose injection device designed for use with a standard 3ml cartridge. This pen features Haselmeier's hidden needle design which hides the needle from the patient before and during injection. Pressing the clip on the pen…


The Softpen is a fully-automatic, reusable injection device featuring Haselmeier’s hidden needle design. This high-quality injection device is designed for use with a standard 3ml cartridge and is made from anodized aluminium to provide years of reliability. Pressing the clip on the pen causes the needle automatically enter the patient's tissue, followed by delivery the…
Quick Contact Haselmeier
Quick Contact Haselmeier

Haselmeier: A further hit model: The Pergoveris® Pen for Merck

Haselmeier has a worldwide reputation for its patient-friendly, high-tech innovations. The new Pergoveris® Pen, developed for its customer Merck, has...
29th November 2017

Organizational changes in quality management at Haselmeier: Mr. Konrad Betzler becomes new CQO (Chief Quality Officer)

Konrad Betzler was appointed the new Chief Quality Officer (CQO) of the entire Haselmeier Group in October 2017 with responsibility...
29th November 2017

Haselmeier Introduces the Award-Winning D-Flex. Just one.

The especially flexible disposable pen D-Flex has been given the GOOD DESIGN™ Award. However, the D-Flex stands out in the...
21st February 2017

Haselmeier AG Appoints Paul Jansen as Senior Advisor and Member of the Board of Directors

Haselmeier, a leader in the development and manufacturing of drug delivery devices is pleased to announce the appointment of Paul...
21st February 2017

Another award for Haselmeier – the German Brand Award 2016

After the triumph of two internationally renowned accolades in 2015- the Good Design™ Award, and the Red Dot Award: Product...
30th June 2016

Haselmeier Group Announces the Extension and Reorganization of its Executive Board

The Haselmeier Group has decided to reinforce and reorganise its Executive Board. Mr. Gert Weber has been nominated by the...
1st July 2015

Haselmeier Honoured at the International Red Dot Design Award 2015: Award for High Design Quality

Haselmeier is proud to announce yet another award for one of its products. Presented annually, the "Red Dot Award" is...
10th June 2015

Haselmeier 2.0: Redesign of the Website

Today, the world's largest and fastest provider of information is the Internet. As markets become ever more transparent, the importance...
2nd June 2015

Haselmeier Receives Prestigious Accolade for Two of their Products: The international GOOD DESIGN™ Award 2014

Welcome news for the Haselmeier Group – two of their products scooped top prizes at the GOOD DESIGN™ Awards. This...
15th May 2015

Haselmeier Group Announces The Relocation of Haselmeier in the United States

Haselmeier Inc. announced the opening of its new office in the Boott Cotton Mills at 126 John Street, Suite 11,...
15th May 2015

New Management Organisation of the Haselmeier Group

Haselmeier was able to successfully grow over the past few years, allowing the company to carve out a solid position...
10th November 2014

Haselmeier announces the launch of INSUPen® EZ in India by Biocon

Haselmeier announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen EZ...
27th October 2014

Biocon Launches Haselmeier’s Insulin Pen in India

Haselmeier has announced that Biocon, one of Asia's premier biotechnology companies, has launched INSUPen® in India. Under the terms of...
15th March 2012

First Application of Haselmeier’s Axis-D Injection Pen in Launched

Haselmeier has announced that the first application of its Axis-D pen platform has been launched. Commissioned by its client Merck...
15th March 2012
Quick Contact Haselmeier

Quick Contact Haselmeier
Quick Contact Haselmeier
Quick Contact Haselmeier

Contact Haselmeier

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.


Finally, complete a quick security check and confirm terms and conditions:

Quick Contact Haselmeier